CDD and AI for Biologics Summit on August 25-27, 2026 in Boston, United States

AI/ML and computational use cases for biologics design and optimization are at a critical turning point. Latent Labs' launch to develop biologics using advanced AI models, Eli Lilly's TuneLab partnering with BigHat Bio and Chai Discovery, and Bayer's collaboration with Cradle on AI-enabled antibody discovery, emphasize the role of AI as the key accelerant in re-architecting biologics workflows to expedite discovery to lead candidate optimization.

URLs:

Website: https://go.evvnt.com/3581934-0?pid=10008

Tickets: https://go.evvnt.com/3581934-2?pid=10008

Brochure: https://go.evvnt.com/3581934-3?pid=10008

Prices: USD 2299.00 - USD 5297.00

Speakers: Mark Aquino, Principal Data Scientist II, AbbVie, Christopher Negron, Principal Research Scientist II, AbbVie and more

Date and Time: 25th August 2026 at 8:30 am to 27th August 2026 at 4:00 pm

Venue details: Hotel Commonwealth, 500 Commonwealth Avenue, Boston, Massachusetts, 02215, United States